These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 6676769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Results of the use of fluphenazine in a depot preparation].
    Marcjan K, Pietruszewska I, Wolak E.
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():176-82. PubMed ID: 829619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J.
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa, Minsker EI, Panteleeva GP, Mazurskii MB, Pekunova LG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Oct 10; 73(5):753-8. PubMed ID: 4718619
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
    Pirozynski T, Chiriţă V, Cosmovici N, Offenberg C, Chiriac ME, Marinescu V, Cojocaru M, Berlescu M, Mungiu A.
    Rev Med Chir Soc Med Nat Iasi; 1989 Oct 10; 93(3):501-9. PubMed ID: 2700035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
    Christodoulidis H, Frangos H.
    Curr Ther Res Clin Exp; 1975 Jul 10; 18(1 pt 2):193-8. PubMed ID: 809234
    [No Abstract] [Full Text] [Related]

  • 19. [Advantages and indications of Moditen-Retard].
    Vallade L.
    Encephale; 1970 Jul 10; ():Suppl:10-3. PubMed ID: 5458707
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J.
    Cesk Psychiatr; 1982 Feb 10; 78(1):49-55. PubMed ID: 7060182
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.